Publicaciones (35) Publicaciones en las que ha participado algún/a investigador/a

2010

  1. 18F-FDG PET bio-metabolic monitoring of neoadjuvant therapy effects in rectal cancer: Focus on nodal disease characteristics

    Radiotherapy and Oncology, Vol. 97, Núm. 2, pp. 212-216

  2. A novel BRCA2 mutation that segregates with breast and prostate cancer in a Spanish family

    Breast Cancer Research and Treatment, Vol. 121, Núm. 1, pp. 219-220

  3. A phase II trial of less than 7 weeks of concomitant cisplatin-paclitaxel chemoradiation in locally advanced cervical cancer

    International Journal of Gynecological Cancer, Vol. 20, Núm. 1, pp. 133-140

  4. ABC transporters as molecular effectors of pancreatic oncogenic pathways: The hedgehog-GLI model

    Journal of Gastrointestinal Cancer, Vol. 41, Núm. 3, pp. 153-158

  5. Activity of a multitargeted chemo-switch regimen (sorafenib, gemcitabine, and metronomic capecitabine) in metastatic renal-cell carcinoma: A phase 2 study (SOGUG-02-06)

    The Lancet Oncology, Vol. 11, Núm. 4, pp. 350-357

  6. Adjuvant endocrine therapy in premenopausal women with breast cancer

    Breast Cancer Research and Treatment, Vol. 123, Núm. SUPPL. 1, pp. 43-47

  7. Complement activation mediates cetuximab inhibition of non-small cell lung cancer tumor growth in vivo

    Molecular Cancer, Vol. 9

  8. Concomitant cisplatin, paclitaxel, and hyperfractionated radiotherapy in locally advanced head and neck cancer: Comparison of two different schedules

    American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 33, Núm. 2, pp. 137-143

  9. Delivery of immunostimulatory monoclonal antibodies by encapsulated hybridoma cells

    Cancer Immunology, Immunotherapy, Vol. 59, Núm. 11, pp. 1621-1631

  10. Development of a novel splice array platform and its application in the identification of alternative splice variants in lung cancer

    BMC Genomics, Vol. 11, Núm. 1

  11. Diagnostic utility of snail in metaplastic breast carcinoma

    Diagnostic Pathology, Vol. 5, Núm. 1

  12. Dose-finding study and pharmacogenomic analysis of fixed-rate infusion of gemcitabine, irinotecan and bevacizumab in pretreated metastatic colorectal cancer patients

    British Journal of Cancer, Vol. 103, Núm. 10, pp. 1529-1535

  13. Epithelial ovarian carcinoma: Current evidences and future perspectives in the first-line setting

    Clinical and Translational Oncology, Vol. 12, Núm. 6, pp. 418-430

  14. Hepatic breast cancer dissemination after an iatrogenic hepatic laceration during talc pleurodesis: A case report

    International Archives of Medicine, Vol. 3, Núm. 1

  15. Impact of the incorporation of tyrosine kinase inhibitor agents on the treatment of patients with a diagnosis of advanced renal cell carcinoma: Study based on experience at the Hospital Universitario Central de Asturias

    Clinical and Translational Oncology, Vol. 12, Núm. 8, pp. 562-567

  16. Improving disease control in advanced colorectal cancer: Panitumumab and cetuximab

    Critical Reviews in Oncology/Hematology, Vol. 74, Núm. 3, pp. 193-202

  17. Intensity-modulated radiation therapy (IMRT) vs. 3D conformal radiotherapy (3DCRT) in locally advanced rectal cancer (LARC): Dosimetric comparison and clinical implications

    Radiation Oncology, Vol. 5, Núm. 1

  18. Ki67: A time-varying biomarker of risk of breast cancer in atypical hyperplasia

    Breast Cancer Research and Treatment, Vol. 121, Núm. 2, pp. 431-437

  19. La coordinación de esfuerzos en casos clínicos complejos: un valor añadido de cuidados paliativos en un hospital universitario

    Anales del sistema sanitario de Navarra, Vol. 33, Núm. 3, pp. 315-318

  20. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: A pooled analysis of individual patient data

    The Lancet Oncology, Vol. 11, Núm. 9, pp. 835-844